| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| BIOLIFE SOLUTIONS INC | 10%+ Owner | Common Stock, par value $0.001 per share | 5,957,165 | $170,059,784 | $28.55 | 15 Oct 2025 | Indirect |
| STANDARD BIOTOOLS INC. | Director, 10%+ Owner | Common Stock, $0.001 par value per share | 72,100,000 | $104,314,280 | $1.45 | 04 Dec 2025 | Indirect |
| MAXCYTE, INC. | 10%+ Owner | Common Stock, par value $0.01 per share | 10,000,000 | $45,300,000 | $4.53 | 03 Oct 2022 | Direct |
| Verve Therapeutics, Inc. | 10%+ Owner | Common Stock | 2,417,596 | $24,175,960 | $10.00 | 21 Jun 2021 | Direct |
| Absci Corp | Director | Common Stock | 6,745,333 | $7,419,866 | $1.10 | 26 Jul 2021 | Direct |
| STANDARD BIOTOOLS INC. | Director, 10%+ Owner | Common Stock, $0.001 par value per share | 2,901,062 | $3,481,274 | $1.20 | 02 Dec 2025 | Direct |
| Tenaya Therapeutics, Inc. | 10%+ Owner | Common Stock | 361,969 | $1,541,988 | $4.26 | 03 Aug 2021 | Indirect |
| Absci Corp | Director | Common Stock | 973,260 | $1,070,586 | $1.10 | 26 Jul 2021 | Indirect |
| Absci Corp | Director | Convertible Note | 0 | 26 Jul 2021 | Direct | ||
| Absci Corp | Director | Convertible Note | 0 | 26 Jul 2021 | Indirect | ||
| Absci Corp | Director | Series E Preferred Stock | 0 | 26 Jul 2021 | Direct | ||
| Tenaya Therapeutics, Inc. | 10%+ Owner | Series B Preferred Stock | 0 | 03 Aug 2021 | Indirect | ||
| Tenaya Therapeutics, Inc. | 10%+ Owner | Series C Preferred Stock | 0 | 03 Aug 2021 | Indirect | ||
| Verve Therapeutics, Inc. | 10%+ Owner | Series A-2 Preferred Stock | 0 | 21 Jun 2021 | Direct | ||
| Verve Therapeutics, Inc. | 10%+ Owner | Series B Preferred Stock | 0 | 21 Jun 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| LAB | STANDARD BIOTOOLS INC. | 02 Dec 2025 | 3 | +$502,570 | 4 | Director, 10%+ Owner | 04 Dec 2025, 20:59 |
| LAB | STANDARD BIOTOOLS INC. | 24 Nov 2025 | 2 | +$10,053,280 | 4 | Director, 10%+ Owner | 26 Nov 2025, 16:58 |
| LAB | STANDARD BIOTOOLS INC. | 18 Nov 2025 | 3 | +$1,374,575 | 4 | Director, 10%+ Owner | 20 Nov 2025, 19:45 |
| LAB | STANDARD BIOTOOLS INC. | 13 Nov 2025 | 3 | +$1,126,775 | 4 | Director, 10%+ Owner | 17 Nov 2025, 18:58 |
| LAB | STANDARD BIOTOOLS INC. | 07 Nov 2025 | 4 | +$1,379,318 | 4 | Director, 10%+ Owner | 12 Nov 2025, 19:46 |
| BLFS | BIOLIFE SOLUTIONS INC | 15 Oct 2025 | 1 | -$21,410,325 | 4 | 10%+ Owner | 17 Oct 2025, 19:55 |
| LAB | STANDARD BIOTOOLS INC. | 09 Sep 2025 | 1 | +$128,920 | 4 | Director, 10%+ Owner | 11 Sep 2025, 21:03 |
| LAB | STANDARD BIOTOOLS INC. | 03 Sep 2025 | 2 | +$635,750 | 4 | Director, 10%+ Owner | 05 Sep 2025, 19:08 |
| LAB | STANDARD BIOTOOLS INC. | 22 Aug 2025 | 3 | +$658,798 | 4 | Director, 10%+ Owner | 26 Aug 2025, 20:46 |
| BLFS | BIOLIFE SOLUTIONS INC | 15 Aug 2025 | 1 | -$12,200,000 | 4 | 10%+ Owner | 21 Aug 2025, 21:10 |
| LAB | STANDARD BIOTOOLS INC. | 13 Aug 2025 | 3 | +$443,033 | 4 | Director, 10%+ Owner | 15 Aug 2025, 21:18 |
| BLFS | BIOLIFE SOLUTIONS INC | 11 Aug 2025 | 1 | -$11,300,000 | 4 | 10%+ Owner | 13 Aug 2025, 18:43 |
| BLFS | BIOLIFE SOLUTIONS INC | 10 Jun 2025 | 1 | -$23,800,000 | 4 | 10%+ Owner | 12 Jun 2025, 20:27 |
| BLFS | BIOLIFE SOLUTIONS INC | 07 Apr 2025 | 0 | $0 | 4/A | 10%+ Owner | 29 Apr 2025, 21:57 |
| LAB | STANDARD BIOTOOLS INC. | 28 Feb 2025 | 4 | +$5,196,320 | 4 | Director, 10%+ Owner | 04 Mar 2025, 20:19 |
| LAB | STANDARD BIOTOOLS INC. | 27 Aug 2024 | 1 | +$546,750 | 4 | Director, 10%+ Owner | 29 Aug 2024, 20:30 |
| LAB | STANDARD BIOTOOLS INC. | 22 Aug 2024 | 3 | +$1,546,237 | 4 | Director, 10%+ Owner | 26 Aug 2024, 20:10 |
| LAB | STANDARD BIOTOOLS INC. | 19 Aug 2024 | 3 | +$2,351,875 | 4 | Director, 10%+ Owner | 21 Aug 2024, 20:47 |
| LAB | STANDARD BIOTOOLS INC. | 14 Aug 2024 | 1 | +$1,913,520 | 4 | Director, 10%+ Owner | 16 Aug 2024, 19:52 |
| LAB | STANDARD BIOTOOLS INC. | 09 Aug 2024 | 3 | +$2,559,641 | 4 | Director, 10%+ Owner | 13 Aug 2024, 20:15 |
| LAB | STANDARD BIOTOOLS INC. | 07 Aug 2024 | 2 | +$1,718,801 | 4 | Director, 10%+ Owner | 09 Aug 2024, 21:34 |
| LAB | STANDARD BIOTOOLS INC. | 02 Aug 2024 | 0 | $0 | 4/A | Director, 10%+ Owner | 04 Mar 2025, 20:03 |
| LAB | STANDARD BIOTOOLS INC. | 18 Jun 2024 | 3 | $0 | 4 | Director, 10%+ Owner | 21 Jun 2024, 20:53 |
| LAB | STANDARD BIOTOOLS INC. | 23 May 2024 | 1 | +$260,000 | 4 | Director, 10%+ Owner | 28 May 2024, 20:45 |
| LAB | STANDARD BIOTOOLS INC. | 20 May 2024 | 3 | +$1,541,795 | 4 | Director, 10%+ Owner | 22 May 2024, 19:53 |
| LAB | STANDARD BIOTOOLS INC. | 15 May 2024 | 3 | +$3,455,544 | 4 | Director, 10%+ Owner | 17 May 2024, 20:11 |
| BLFS | BIOLIFE SOLUTIONS INC | 30 Apr 2024 | 2 | $0 | 4 | 10%+ Owner | 02 May 2024, 17:05 |
| LAB | STANDARD BIOTOOLS INC. | 18 Mar 2024 | 4 | +$127,428,614 | 4 | Director, 10%+ Owner | 20 Mar 2024, 17:54 |
| LAB | STANDARD BIOTOOLS INC. | 04 Mar 2024 | 2 | +$646,169 | 4 | Director, 10%+ Owner | 06 Mar 2024, 19:20 |
| LAB | STANDARD BIOTOOLS INC. | 05 Jan 2024 | 2 | $0 | 4 | Director, 10%+ Owner | 09 Jan 2024, 20:51 |
| BLFS | BIOLIFE SOLUTIONS INC | 19 Oct 2023 | 1 | +$10,374,976 | 4 | 10%+ Owner | 23 Oct 2023, 17:42 |
| BLFS | BIOLIFE SOLUTIONS INC | 09 Aug 2023 | 1 | +$771,744 | 4 | 10%+ Owner | 11 Aug 2023, 17:01 |
| BLFS | BIOLIFE SOLUTIONS INC | 19 May 2023 | 2 | +$1,673,220 | 4 | 10%+ Owner | 23 May 2023, 17:46 |
| LAB | STANDARD BIOTOOLS INC. | 17 May 2023 | 3 | +$2,631,335 | 4 | Director, 10%+ Owner | 19 May 2023, 21:00 |
| BLFS | BIOLIFE SOLUTIONS INC | 16 May 2023 | 3 | +$1,594,973 | 4 | 10%+ Owner | 18 May 2023, 20:31 |
| MXCT | MAXCYTE, INC. | 03 Oct 2022 | 1 | -$4,525,084 | 4 | 10%+ Owner | 05 Oct 2022, 16:24 |
| MXCT | MAXCYTE, INC. | 01 Jul 2022 | 1 | -$13,912,856 | 4 | 10%+ Owner | 06 Jul 2022, 17:01 |
| LAB | STANDARD BIOTOOLS INC. | 04 Apr 2022 | 1 | $0 | 4 | Director, 10%+ Owner | 06 Apr 2022, 17:54 |
| LAB | STANDARD BIOTOOLS INC. | 04 Apr 2022 | 0 | $0 | 3 | Director | 06 Apr 2022, 17:54 |
| BLFS | BIOLIFE SOLUTIONS INC | 01 Sep 2021 | 1 | $0 | 4/A | 10%+ Owner | 19 May 2023, 20:32 |
| TNYA | Tenaya Therapeutics, Inc. | 03 Aug 2021 | 6 | +$12,750,000 | 4 | 10%+ Owner | 04 Aug 2021, 18:33 |
| MXCT | MAXCYTE, INC. | 30 Jul 2021 | 1 | +$23,400,000 | 4 | 10%+ Owner | 03 Aug 2021, 18:08 |
| MXCT | MAXCYTE, INC. | 29 Jul 2021 | 0 | $0 | 3 | 10%+ Owner | 30 Jul 2021, 14:56 |
| TNYA | Tenaya Therapeutics, Inc. | 29 Jul 2021 | 0 | $0 | 3 | 10%+ Owner | 29 Jul 2021, 19:28 |
| ABSI | Absci Corp | 26 Jul 2021 | 7 | -$538,356 | 4 | Director | 28 Jul 2021, 16:33 |
| ABSI | Absci Corp | 21 Jul 2021 | 0 | $0 | 3 | Director, 10%+ Owner | 21 Jul 2021, 20:53 |
| VERV | Verve Therapeutics, Inc. | 21 Jun 2021 | 5 | +$20,900,000 | 4 | 10%+ Owner | 22 Jun 2021, 17:12 |
| VERV | Verve Therapeutics, Inc. | 16 Jun 2021 | 0 | $0 | 3 | 10%+ Owner | 16 Jun 2021, 19:27 |